102
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Impact of mild exacerbation on COPD symptoms in a Japanese cohort

, , , , , , , , & show all
Pages 1269-1278 | Published online: 09 Jun 2016

References

  • VestboJHurdSSAgustíAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
  • Soler-CataluñaJJMartínez-GarcíaMARomán SánchezPSalcedoENavarroMOchandoRSevere acute exacerbations and mortality in patients with chronic obstructive pulmonary diseaseThorax2005601192593116055622
  • AlmagroPSorianoJBHerediaJLWorking Group on COPDSpanish Society of Internal MedicineShort- and medium-term prognosis in patients hospitalized for COPD exacerbation: the CODEX indexChest2014145597298024077342
  • de Miguel-DíezJJiménez-GarcíaRCarrasco-GarridoPTrends in hospital admissions for acute exacerbation of COPD in Spain from 2006 to 2010Respir Med2013107571772323421969
  • BlasiFCesanaGMantovaniLGThe clinical and economic impact of exacerbations of chronic obstructive pulmonary disease: a cohort of hospitalized patientsPLoS One201496e10122824971791
  • WedzichaJABrillSEAllinsonJPDonaldsonGCMechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary diseaseBMC Med20131118123945277
  • HurstJRVestboJAnzuetoAEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) InvestigatorsSusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
  • WedzichaJADecramerMFickerJHAnalysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group studyLancet Respir Med20131319920924429126
  • TomiokaRKawayamaTHoshinoT“Frequent exacerbator” is a phenotype of poor prognosis in Japanese patients with chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis20161120721626893552
  • AnthonisenNRManfredaJWarrenCPHershfieldESHardingGKNelsonNAAntibiotic therapy in exacerbations of chronic obstructive pulmonary diseaseAnn Intern Med198710621962043492164
  • MiravitllesMFerrerMPontAIMPAC Study GroupEffect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up studyThorax200459538739515115864
  • SeemungalTADonaldsonGCBhowmikAJeffriesDJWedzichaJATime course and recovery of exacerbations in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200016151608161310806163
  • WilkinsonTMDonaldsonGCHurstJRSeemungalTAWedzichaJAEarly therapy improves outcomes of exacerbations of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2004169121298130314990395
  • LangsetmoLPlattRWErnstPBourbeauJUnderreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohortAm J Respir Crit Care Med2008177439640118048806
  • FukuchiYFernandezLKuoHPEfficacy of tiotropium in COPD patients from Asia: a subgroup analysis from the UPLIFT trialRespirology201116582583521539680
  • TanabeNMuroSHiraiTImpact of exacerbations on emphysema progression in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2011183121653165921471102
  • SuzukiMMakitaHItoYMHokkaido COPD Cohort Study InvestigatorsClinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort studyEur Respir J20144351289129724232696
  • MiyazakiMNakamuraHChubachiSKeio COPD Comorbidity Research (K-CCR) GroupAnalysis of comorbid factors that increase the COPD assessment test scoresRespir Res2014151324502760
  • ChubachiSNakamuraHSasakiMKeio COPD Comorbidity Research (K-CCR) GroupPolymorphism of LRP5 gene and emphysema severity are associated with osteoporosis in Japanese patients with or at risk for COPDRespirology201520228629525392953
  • MiyazakiMNakamuraHTakahashiSKeio COPD Comorbidity Research (K-CCR) GroupThe reasons for triple therapy in stable COPD patients in Japanese clinical practiceInt J Chron Obstruct Pulmon Dis2015101053105926082629
  • NagaiKMakitaHSuzukiMHokkaido COPD Cohort Study InvestigatorsDifferential changes in quality of life components over 5 years in chronic obstructive pulmonary disease patientsInt J Chron Obstruct Pulmon Dis20151074575725914531
  • SeemungalTADonaldsonGCPaulEABestallJCJeffriesDJWedzichaJAEffect of exacerbation on quality of life in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19981575 Pt 1141814229603117
  • JonesPWQuirkFHBaveystockCMLittlejohnsPA self-complete measure of health status for chronic airflow limitation. The St. George’s Respiratory QuestionnaireAm Rev Respir Dis19921456132113271595997
  • HajiroTNishimuraKTsukinoMIkedaAKoyamaHIzumiTComparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19981573 Pt 17857909517591
  • HajiroTNishimuraKTsukinoMIkedaAKoyamaHIzumiTAnalysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19981584118511899769280
  • JonesPWHardingGBerryPWiklundIChenWHKline LeidyNDevelopment and first validation of the COPD assessment testEur Respir J200934364865419720809
  • KwonNAminMHuiDSValidity of the COPD assessment test translated into local languages for Asian patientsChest2013143370371023460156
  • CamiciottoliGBigazziFPaolettiMCestelliLLavoriniFPistolesiMPulmonary function and sputum characteristics predict computed tomography phenotype and severity of COPDEur Respir J201342362663523258785
  • TanabeNMuroSTanakaSEmphysema distribution and annual changes in pulmonary function in male patients with chronic obstructive pulmonary diseaseRespir Res2012133122512922
  • KonSSCanavanJLJonesSEMinimum clinically important difference for the COPD Assessment Test: a prospective analysisLancet Respir Med20142319520324621681
  • RaudenbushSWBrykASHierarchical Linear ModelsNewbury Park, NJSage2002
  • HalpinDMDecramerMCelliBKestenSLiuDTashkinDPExacerbation frequency and course of COPDInt J Chron Obstruct Pulmon Dis2012765366123055714
  • DonaldsonGCSeemungalTAPatelISLloyd-OwenSJWilkinsonTMWedzichaJALongitudinal changes in the nature, severity and frequency of COPD exacerbationsEur Respir J200322693193614680081
  • PittaFTroostersTProbstVSSpruitMADecramerMGosselinkRPhysical activity and hospitalization for exacerbation of COPDChest2006129353654416537849
  • MackayAJDonaldsonGCPatelARSinghRKowlessarBWedzichaJADetection and severity grading of COPD exacerbations using the exacerbations of chronic pulmonary disease tool (EXACT)Eur Respir J201443373574423988767
  • TrappenburgJCTouwenIde Weert-van OeneGHDetecting exacerbations using the clinical COPD questionnaireHealth Qual Life Outcomes2010810220846428
  • McGarveyLLeeAJRobertsJGruffydd-JonesKMcKnightEHaughneyJCharacterisation of the frequent exacerbator phenotype in COPD patients in a large UK primary care populationRespir Med2015109222823725613107
  • BrekkePHOmlandTSmithPSøysethVUnderdiagnosis of myocardial infarction in COPD – cardiac infarction injury score (CIIS) in patients hospitalised for COPD exacerbationRespir Med200810291243124718595681
  • TeradaKMuroSSatoSImpact of gastro-oesophageal reflux disease symptoms on COPD exacerbationThorax2008631195195518535116
  • MartinezCHOkajimaYMurraySCOPD Gene InvestigatorsImpact of self-reported gastroesophageal reflux disease in subjects from COPD Gene cohortRespir Res2014156224894541
  • XuWColletJPShapiroSIndependent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizationsAm J Respir Crit Care Med2008178991392018755925
  • TatsumiKKasaharaYKurosuKRespiratory Failure Research Group in JapanClinical phenotypes of COPD: results of a Japanese epidemiological surveyRespirology20049333133615363004
  • TakahashiSBetsuyakuTThe chronic obstructive pulmonary disease comorbidity spectrum in Japan differs from that in western countriesRespir Investig2015536259270
  • DaiMYQiaoJPXuYHFeiGHRespiratory infectious phenotypes in acute exacerbation of COPD: an aid to length of stay and COPD Assessment TestInt J Chron Obstruct Pulmon Dis2015102257226326527871
  • GeorgeSNGarchaDSWedzichaJAHuman rhinovirus infection during naturally occurring COPD exacerbationsEur Respir J2014441879624627537
  • CalverleyPMAndersonJACelliBTORCH InvestigatorsSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
  • TashkinDPCelliBSennSUPLIFT Study InvestigatorsA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med20083591543155418836213
  • GadouryMASchwartzmanKRouleauMChronic Obstructive Pulmonary Disease Axis of the Respiratory Health Network, Fonds de la recherche en santé du Québec (FRSQ)Self-management reduces both short- and long-term hospitalisation in COPDEur Respir J200526585385716264046